rs202192818

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 4P and 4B. PP3_StrongBS2

The NM_006514.4(SCN10A):​c.472T>G​(p.Tyr158Asp) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.000398 in 1,613,694 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a pathogenic outcome for this variant. 2/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. Y158Y) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00030 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00041 ( 1 hom. )

Consequence

SCN10A
NM_006514.4 missense, splice_region

Scores

9
8
1
Splicing: ADA: 0.0004975
2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:1U:9B:1

Conservation

PhyloP100: 5.23

Publications

13 publications found
Variant links:
Genes affected
SCN10A (HGNC:10582): (sodium voltage-gated channel alpha subunit 10) The protein encoded by this gene is a tetrodotoxin-resistant voltage-gated sodium channel alpha subunit. The properties of the channel formed by the encoded transmembrane protein can be altered by interaction with different beta subunits. This protein may be involved in the onset of pain associated with peripheral neuropathy. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jun 2014]
SCN10A Gene-Disease associations (from GenCC):
  • episodic pain syndrome, familial, 2
    Inheritance: AD Classification: STRONG, LIMITED, NO_KNOWN Submitted by: Illumina, Labcorp Genetics (formerly Invitae), Ambry Genetics, PanelApp Australia
  • sodium channelopathy-related small fiber neuropathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Brugada syndrome
    Inheritance: Unknown, AD Classification: LIMITED, NO_KNOWN Submitted by: Genomics England PanelApp, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PP3
MetaRNN computational evidence supports a deleterious effect, 0.985
BS2
High AC in GnomAd4 at 46 AD,Unknown gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_006514.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SCN10A
NM_006514.4
MANE Select
c.472T>Gp.Tyr158Asp
missense splice_region
Exon 5 of 28NP_006505.4Q9Y5Y9
SCN10A
NM_001293306.2
c.472T>Gp.Tyr158Asp
missense splice_region
Exon 4 of 27NP_001280235.2Q9Y5Y9
SCN10A
NM_001293307.2
c.472T>Gp.Tyr158Asp
missense splice_region
Exon 4 of 26NP_001280236.2Q9Y5Y9

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SCN10A
ENST00000449082.3
TSL:1 MANE Select
c.472T>Gp.Tyr158Asp
missense splice_region
Exon 5 of 28ENSP00000390600.2Q9Y5Y9
SCN10A
ENST00000643924.1
c.472T>Gp.Tyr158Asp
missense splice_region
Exon 4 of 27ENSP00000495595.1A0A2R8Y6J6
SCN10A
ENST00000655275.1
c.472T>Gp.Tyr158Asp
missense splice_region
Exon 5 of 28ENSP00000499510.1A0A590UJM0

Frequencies

GnomAD3 genomes
AF:
0.000302
AC:
46
AN:
152232
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000121
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000327
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000470
Gnomad OTH
AF:
0.00191
GnomAD2 exomes
AF:
0.000231
AC:
58
AN:
251360
AF XY:
0.000162
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000174
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000139
Gnomad NFE exome
AF:
0.000396
Gnomad OTH exome
AF:
0.000652
GnomAD4 exome
AF:
0.000408
AC:
596
AN:
1461462
Hom.:
1
Cov.:
31
AF XY:
0.000366
AC XY:
266
AN XY:
727034
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33474
American (AMR)
AF:
0.000201
AC:
9
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26128
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39680
South Asian (SAS)
AF:
0.0000232
AC:
2
AN:
86218
European-Finnish (FIN)
AF:
0.000337
AC:
18
AN:
53348
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5766
European-Non Finnish (NFE)
AF:
0.000496
AC:
551
AN:
1111754
Other (OTH)
AF:
0.000265
AC:
16
AN:
60374
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.471
Heterozygous variant carriers
0
30
60
91
121
151
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000302
AC:
46
AN:
152232
Hom.:
0
Cov.:
33
AF XY:
0.000363
AC XY:
27
AN XY:
74376
show subpopulations
African (AFR)
AF:
0.000121
AC:
5
AN:
41462
American (AMR)
AF:
0.000327
AC:
5
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5200
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4836
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10620
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.000470
AC:
32
AN:
68036
Other (OTH)
AF:
0.00191
AC:
4
AN:
2094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
2
4
7
9
11
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000435
Hom.:
0
Bravo
AF:
0.000215
TwinsUK
AF:
0.00162
AC:
6
ALSPAC
AF:
0.000519
AC:
2
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000581
AC:
5
ExAC
AF:
0.000264
AC:
32
EpiCase
AF:
0.000600
EpiControl
AF:
0.000178

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
3
-
Episodic pain syndrome, familial, 2 (3)
-
3
-
not provided (3)
1
1
-
Brugada syndrome 1 (2)
-
1
-
Brugada syndrome (1)
-
-
1
Cardiovascular phenotype (1)
-
1
-
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.13
BayesDel_addAF
Uncertain
0.15
D
BayesDel_noAF
Pathogenic
0.42
CADD
Benign
17
DANN
Uncertain
0.99
DEOGEN2
Pathogenic
0.85
D
Eigen
Uncertain
0.55
Eigen_PC
Uncertain
0.35
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.95
D
M_CAP
Pathogenic
0.63
D
MetaRNN
Pathogenic
0.98
D
MetaSVM
Pathogenic
1.1
D
MutationAssessor
Pathogenic
3.2
M
PhyloP100
5.2
PrimateAI
Uncertain
0.63
T
PROVEAN
Pathogenic
-8.8
D
REVEL
Pathogenic
0.88
Sift
Uncertain
0.0010
D
Sift4G
Uncertain
0.029
D
Polyphen
1.0
D
Vest4
0.82
MVP
0.98
MPC
0.44
ClinPred
0.96
D
GERP RS
2.7
Varity_R
0.79
gMVP
0.89
Mutation Taster
=22/78
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.00050
dbscSNV1_RF
Benign
0.0080
SpliceAI score (max)
0.34
Details are displayed if max score is > 0.2
DS_AL_spliceai
0.34
Position offset: 1

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs202192818; hg19: chr3-38812897; COSMIC: COSV101479466; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.